Expansion Of The Genetic Surveillance State: Taking The Blood Of Babies Born To Mississippi Teens
By Kashmir Hill,
Forbes
| 07. 02. 2013
In what sounds like a plot twist from a dystopic-future novel, Mississippi
is now requiring hospitals to store the blood of babies born to mothers 16 and younger. The
new law, which went into effect on Monday, July 1, is meant to discourage teen pregnancy, according to its drafters, but in a very roundabout way.
Any time a teen mom doesn’t know who the father is, or won’t say who the father is, or says the father is over 21, a hospital is required to take a blood sample from the baby’s umbilical cord and put it on ice. DNA will then be extracted from that blood and used to hunt down the (presumably) older men who had sex with the young women. They can be charged with statutory rape if they are more than 3 years older than the under-16 moms. The state hopes this will discourage cradle-robbers/cradle-makers in the future.
Via
NPR:
Starting in July, doctors and midwives in the state will be required by law to collect samples of umbilical cord blood from babies born...
Related Articles
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...